n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine has been researched along with Paralysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holaday, JW; Long, JB; Mobley, WC | 1 |
| Holaday, JW; Long, JB; Petras, JM | 1 |
2 other study(ies) available for n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine and Paralysis
| Article | Year |
|---|---|
Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
Topics: Animals; Dose-Response Relationship, Drug; Dynorphins; Enkephalin, Leucine; Hindlimb; Injections, Spinal; Male; Motor Activity; Nociceptors; Paralysis; Peptide Fragments; Rats; Rats, Inbred Strains; Spinal Cord | 1988 |
Neurologic deficits and neuronal injury in rats resulting from nonopioid actions of the delta opioid receptor antagonist ICI 174864.
Topics: Animals; Drug Tolerance; Dynorphins; Enkephalin, Leucine; Male; Narcotic Antagonists; Neurons; Paralysis; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Spinal Cord | 1988 |